Nichi-Iko Pharmaceutical Co., Ltd.
日医工株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4541
FY2021 · 2022-03-31
| Gross margin | 2.2% |
| Operating margin | -61.5% |
| Net margin | -58.6% |
| Return on equity | -783.8% |
| Return on assets | -40.3% |
| Revenue growth (YoY) | -4.9% |
| EPS (basic) | ¥-1,554.37 |
| EPS growth (YoY) | — |
| Current ratio | — |
| Equity ratio | 5.1% |
| Book value / share | ¥110.6 |
| Free cash flow | -27,729 M |